In this study, building on previous research, we demonstrated the effect of niclosamide in enhancing HCC sensitivity to sorafenib, in particular through IGF-1/IGF-1R activation, stemness regulation, and metabolic changes. Here, IGF1 is linked to hepatocellular carcinoma.